A new coronovirus test can help prevent an infection if you have an immune system weakened by an underlying condition, like anemia, that is already under way.
The new test, which was announced in January, is the first of its kind to detect the virus in the bloodstream and could help doctors identify people at high risk for infection.
“It’s like having a second set of eyes on you and you know that there are two sets of eyes,” Dr. David Tannenbaum, a scientist at the National Institutes of Health, said at a news conference on Tuesday.
“And then you can have the first set of pupils in your head, and you can see what’s going on.”
The new coronivirus test is based on a combination of genetic and clinical tests.
It’s meant to be used on people who are not immune and could be at increased risk for the virus, according to the U.S. Centers for Disease Control and Prevention.
The new tests will also be used to determine whether someone has been exposed to the coronaviru virus.
The CDC estimates that between 50,000 and 90,000 Americans have tested positive for the coronoviruses, but it’s unclear how many people are actually infected.
The tests can be performed using a swab or a swatch of tissue.
The test comes with a $199 charge.
The tests are designed to detect antibodies produced by the coroniviruses coronavirevirus and simian immunodeficiency virus.
The results are then compared to the results from a blood test.
The Centers for Medicare and Medicaid Services has also released a list of countries where tests can now be ordered through the website.
In the United States, tests are being ordered through a federal program that provides free testing for people who don’t have insurance.
The U.K., Denmark, the Netherlands and France have already ordered tests, according, and the results are expected to be available in early 2018.
The CDC has also been in contact with the manufacturer, Verisign.